Our Portfolio

PharmatrophiX

Frank Longo, MD, PhD | California, United States

Project Overview

  • Biotechnology/For Profit Organization Type
  • $300,000 Funding Amount
  • 2/1/08 — 1/31/09 Project Duration
  • Drug Discovery Program
  • Growth Factors/Neurotrophic Factors Target
  • ADME and PK Therapeutic Stage
  • Closed Status

PharmatrophiX

Frank Longo, MD, PhD | California, United States

Inhibition of Alzheimer-related neurodegeneration by small molecule neurotrophin receptor ligands

GET IN TOUCH